Journal Article


T N Walsh
P J Byrne
D A McNamara
A Nasyr
S Tormey



therapy administration dosage manometry middle aged peristalsis fluorouracil humans cisplatin combined modality therapy female hydrogen ion concentration monitoring ambulatory physiopathology esophagus male radiotherapy dosage adenocarcinoma esophageal neoplasms carcinoma squamous cell deglutition disorders

Effect of tumour and chemoradiotherapy on oesophageal motility. (2003)

Abstract The contribution of dysmotility to dysphagia in oesophageal cancer is unclear. To examine oesophageal motility in patients with oesophageal carcinoma and to assess the effect of chemoradiotherapy on motility. Stationary manometry and 24-hour pH-metry were performed in 12 patients with oesophageal carcinoma and one week following completion of chemoradiotherapy using 5-fluorouracil (5-FU), cisplatin and 40Gy radiotherapy. All patients had abnormal motility prior to treatment. Peristalsis was impaired in 11 patients with a mean (SD) of 25% (9) of waves normally propagated. Eight patients had 20% or more simultaneous waves. Following chemoradiotherapy, the percentage of waves normally propagated increased from 25% (9) to 521% (10) (p < 0.03) and normal peristalsis was restored in four patients. The percentage of simultaneous waves decreased from 38% (11) to 21.6% (10) (p = 0.129) while the percentage of dropped or increased waves decreased from 20% (11) to 8.3% (4) (p = 0.264). Oesophageal motility is disturbed in oesophageal cancer. Dysphagia in oesophageal cancer may be partly explained by oesophageal dysmotility. This is improved by chemotherapy.
Collections Ireland -> IT Blanchardstown -> PubMed

Full list of authors on original publication

T N Walsh, P J Byrne, D A McNamara, A Nasyr, S Tormey

Experts in our system

T N Walsh
IT Blanchardstown
Total Publications: 53
Deirdre McNamara
IT Tallaght
Total Publications: 51